methyl (2S,3R)-3-cyclopropyl-3-(3-hydroxy-4-iodophenyl)-2-methylpropanoate, 98%, 250mg

5,8-Dimethoxy-3,4-dihydroquinolin-2(1H)-one, 95%, 1g

2-Methyl-3-(3,4-methylenedioxyphenyl)propanal, 95.0%, 5g

O-tert-Butyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine>98.0%(HPLC)(T)5g

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(dipentylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 97%, 1g

9-Fluorenecarboxylic Acid>97.0%(T)25g

Pentoxyifylline, >99%, 25g

Transition piece NS-KS Ground joint cone on spherical joint connection, 29, 1 Piece

(1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid, 100mg

2-(4-Bromo-2-fluorophenyl)pyridine, 97.0%, 5g

1-(piperidin-1-ylmethyl)-1H-benzo[d]imidazole, 95.0%, 250mg

2-Phenylbenzo[d]thiazole, 95.0%, 25g

3-(Trifluoromethyl)benzoic acid, 99.0%, 25g